Concerta vs Ritalin LA
MEDICATION COMPARISON · FROM FDA LABELS AND HEAD-TO-HEAD STUDIES
Reviewed by Tariq Halim, MD · Last medical review: October 29, 2026 · Editorial policy
Side-by-side facts (from each FDA label)
Each cell is copied from that product’s key facts, which cite its current FDA prescribing information. Durations and doses come from each product’s own label studies; they are not a head-to-head comparison.
| Concerta | Ritalin LA | |
|---|---|---|
| Drug class | CNS Stimulant · Methylphenidates | CNS Stimulant · Methylphenidates |
| Active ingredient | methylphenidate hydrochloride | methylphenidate hydrochloride |
| FDA-approved ages | 6 to 65 years (FDA label) | Children 6 to 12 years (FDA label); not recommended under 6 |
| Form and strengths | Extended-release tablet (OROS); 18 mg, 27 mg, 36 mg, 54 mg tablets (72 mg doses use a combination of tablets) | Extended-release capsule (bimodal bead); 10 mg, 20 mg, 30 mg, 40 mg (brand 60 mg capsule previously discontinued) |
| Usual dose and maximum (label) | New to methylphenidate: start 18 mg once daily (adults 18 or 36 mg); maximum 54 mg/day (ages 6–12) or 72 mg/day (13–65). | Start 20 mg once daily (10 mg if a lower start is appropriate); doses above 60 mg/day are not recommended. |
| Duration (label) | About 10–12 hours after a morning dose; benefit lasted through 12 hours in the label’s studies in children. | Usually about 8 hours after a morning dose; the label gives no fixed duration. |
| DEA schedule | Schedule II controlled substance (CII) | Schedule II controlled substance (CII) |
| Generic | Generic available (see Generic manufacturers) | Generic available (see Generic manufacturers) |
| Label date | Prescribing Information revised 04/2026 (DailyMed) | Prescribing Information revised 09/2025 (DailyMed) |
| Availability (site status, Oct 2026) | ER tablet shortage · brand available | Sources differ on brand status |
Main differences in plain words
- Both contain methylphenidate hydrochloride.
- Form: Concerta: extended-release tablet (OROS); Ritalin LA: extended-release capsule (bimodal bead).
- Controlled status: both: Schedule II controlled substance (CII).
- Generic: Concerta: Generic available; Ritalin LA: Generic available.
What studies compare them
The studies below include at least one direct (head-to-head) comparison of Concerta and Ritalin LA or their active formulations. Only head-to-head trials, analyses of them and network meta-analyses are used for comparisons on this page; read the note under each study for what it can and cannot show.
-
Ritalin LA vs Concerta
In a classroom study, Ritalin LA 20 mg improved attention and behavior more than Concerta 18 mg or 36 mg over the first 4 hours after dosing; over 8 hours most differences were no longer significant.
A direct comparison of Ritalin LA with Concerta in children.
Double-blind crossover, children 6–12. SKAMP combined AUC(0–4): RLA −2.05 vs CON 18 mg −0.78 (p<0.001) and CON 36 mg −1.01 (p=0.003). AUC(0–8): RLA −3.58 vs −1.70 (p=0.010) and −2.22 (p=0.061). Attention AUC(0–8) differences not significant.
Lopez F, Silva R, Pestreich L, et al. (2003). Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day. Paediatr Drugs 5(8):545-55. DOI · PubMed 12895137
Switching between them (label)
What each FDA label says about starting it after another medicine. Switch the clinician view on to see the full label wording and any dose tables. More in the switching guide.
Concerta (label section 2.4, Prescribing Information, revised 04/2026): If you take short-acting methylphenidate two or three times a day, the Concerta label gives a matching once-a-morning starting dose.
Starting dose for patients switching from immediate-release methylphenidate given two or three times daily (10–60 mg/day). The 72 mg dose is only for patients 13–65 years old. Adjust in 18 mg steps at weekly intervals.
| Previous immediate-release methylphenidate | Concerta starting dose |
|---|---|
| 5 mg two or three times daily | 18 mg every morning |
| 10 mg two or three times daily | 36 mg every morning |
| 15 mg two or three times daily | 54 mg every morning |
| 20 mg two or three times daily | 72 mg every morning (ages 13–65 only) |
Ritalin LA (label section 2.3, Prescribing Information, revised 09/2025): If you take methylphenidate tablets twice a day, the label gives the matching once-daily capsule dose.
Conversion from Ritalin (methylphenidate hydrochloride tablets) taken twice daily to Ritalin LA once daily.
| Ritalin (methylphenidate tablets), twice daily | Ritalin LA, once daily |
|---|---|
| 5 mg | 10 mg |
| 10 mg | 20 mg |
| 15 mg | 30 mg |
| 20 mg | 40 mg |
| 30 mg | 60 mg |
Ritalin LA (label section 2.4, Prescribing Information, revised 09/2025): From other long-acting methylphenidate products, the dose is worked out again from the start.
From other methylphenidate products: stop the old product and titrate; do not substitute milligram-for-milligram (different methylphenidate base compositions and pharmacokinetics).
For clinicians
Label facts are from each product’s current prescribing information (Concerta: revised 04/2026; Ritalin LA: revised 09/2025). Evidence summaries show the study detail and funding; comparative statements are limited to head-to-head trials, analyses of them and network meta-analyses. Indirect comparisons (for example, matching-adjusted indirect comparisons) are not used for efficacy claims.
Talk to your prescriber. These two medicines are not interchangeable at the same dose unless a label says so. Bring this page to your appointment if it helps, but do not change, stop or swap medicines on your own.
Frequently asked questions
What is the difference between Concerta and Ritalin LA?
Concerta contains methylphenidate hydrochloride (extended-release tablet (OROS)); Ritalin LA contains methylphenidate hydrochloride (extended-release capsule (bimodal bead)). Concerta: Schedule II controlled substance (CII). Ritalin LA: Schedule II controlled substance (CII). The side-by-side table on this page lists approved ages, doses, duration and generic status from each label.
Is Concerta more effective than Ritalin LA?
Lopez 2003: In a classroom study, Ritalin LA 20 mg improved attention and behavior more than Concerta 18 mg or 36 mg over the first 4 hours after dosing; over 8 hours most differences were no longer significant. Results from one study population may not apply to every patient; the best choice depends on the person.
Which lasts longer, Concerta or Ritalin LA?
Per the labels: Concerta: About 10–12 hours after a morning dose; benefit lasted through 12 hours in the label’s studies in children. Ritalin LA: Usually about 8 hours after a morning dose; the label gives no fixed duration. These figures come from separate label studies, not from one study comparing the two. In a head-to-head study (Lopez 2003): In a classroom study, Ritalin LA 20 mg improved attention and behavior more than Concerta 18 mg or 36 mg over the first 4 hours after dosing; over 8 hours most differences were no longer significant.
Can you switch from Concerta to Ritalin LA?
Neither label gives a milligram conversion between these two products. Concerta label: Starting dose for patients switching from immediate-release methylphenidate given two or three times daily (10–60 mg/day). The 72 mg dose is only for patients 13–65 years old. Adjust in 18 mg steps at weekly intervals. Ritalin LA label: Conversion from Ritalin (methylphenidate hydrochloride tablets) taken twice daily to Ritalin LA once daily. From other methylphenidate products: stop the old product and titrate; do not substitute milligram-for-milligram (different methylphenidate base compositions and pharmacokinetics). Any switch is planned and adjusted by the prescriber.
Are Concerta and Ritalin LA available as generics?
Concerta: Generic available. Ritalin LA: Generic available. Current supply is tracked on the availability tracker page.
Sources
- Janssen Pharmaceuticals, Inc. Concerta (methylphenidate HCl) Extended-Release Tablets Prescribing Information, revised 04/2026. DailyMed (accessed Oct 2026).
- Novartis Pharmaceuticals Corporation. Ritalin LA (methylphenidate hydrochloride) extended-release capsules, CII. Prescribing Information, revised 09/2025. FDA label (NDA 021284); DailyMed (accessed Oct 2026).
- Lopez F, Silva R, Pestreich L, et al. Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day. Paediatr Drugs. 2003;5(8):545-55. PubMed